Ab Initio at ARCS 2022
Ab Initio is pleased to announce it is a sponsor of the 2022 ARCS annual conference from the 23-25 May 2022 at the Sydney International Convention & Exhibition Centre .
The ARCS Annual Conference is Australia’s premier event for health industry; bringing together professionals from across the sector from government and industry including regulatory affairs, medical affairs through to clinical trials and manufacturing.
Ab Initio is presenting its FastTrack solution that enables innovators to take new therapeutics from concept into early phase clinical trials via its R&D and manufacturing capabilities. Ab Initio has state-of-the-art R&D formulation and manufacturing facilities to offer local industry accesses to quality products for clinical trials. To learn more about the services Ab Initio Pharma offers, come and visit us at our Booth.
Ab Initio Pharma Ltd was founded in 2019. A spin-off by the University of Sydney, in partnership with Sydney Local Health District and the peak industry body, ARCS. Ab Initio provides innovators across Australia and globally with a flexible platform to rapidly translate bench-top discoveries to clinical trial products.
ARCS is an Australian based professional organisation which focuses on career long professional development for its members in the therapeutic goods sector. ARCS provides education, competency building and information sharing within communities of practice, and targeted advocacy and collaboration with a range of stakeholders.
